Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

作者信息

Wilson A J, Baum M, Brinkley D M, Dossett J A, McPherson K, Patterson J S, Rubens R D, Smiddy F G, Stoll B A, Richards D

出版信息

World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.

DOI:10.1007/BF01655191

PMID:3904233

Abstract

摘要

相似文献

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.

Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.他莫昔芬作为早期乳腺癌治疗单一辅助药物的对照试验。“诺瓦得士”辅助治疗试验组织。

Br J Cancer. 1988 Jun;57(6):608-11. doi: 10.1038/bjc.1988.138.

Adjuvant systemic therapy for early breast cancer: progress and controversies.早期乳腺癌的辅助性全身治疗：进展与争议

Clin Cancer Res. 2001 Jul;7(7):1839-42.

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation.

Lancet. 1985 Apr 13;1(8433):836-40.

Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh.

Lancet. 1987 Jul 25;2(8552):171-5.

Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.接受乳房切除术及辅助化疗（使用或不使用他莫昔芬且未进行放疗）治疗的可手术乳腺癌患者的局部区域复发模式：五项国家外科辅助乳腺和肠道项目随机临床试验的结果

J Clin Oncol. 2004 Nov 1;22(21):4247-54. doi: 10.1200/JCO.2004.01.042. Epub 2004 Sep 27.

Adjuvant tamoxifen in early breast cancer.早期乳腺癌的辅助性他莫昔芬治疗

Lancet. 1987 Jul 25;2(8552):191-2.

Ovarian ablation as adjuvant therapy for early-stage breast cancer.卵巢去势作为早期乳腺癌的辅助治疗

Cancer Treat Res. 1998;94:158-80.

Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.

Lancet. 1983 Feb 5;1(8319):257-61.

Adjuvant tamoxifen in breast cancer.乳腺癌的辅助性他莫昔芬治疗

Cancer Treat Rev. 1984 Dec;11(4):321-3. doi: 10.1016/0305-7372(84)90032-x.

引用本文的文献

Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.他莫昔芬部分抑制雌激素诱导的大鼠乳腺肿瘤发生：氧化应激和雌激素反应之间的平衡。

PLoS One. 2011;6(9):e25125. doi: 10.1371/journal.pone.0025125. Epub 2011 Sep 26.

DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.他莫昔芬和托瑞米芬对雌性大鼠肝脏的DNA损伤以及代谢和DNA修复酶基因表达的改变

Cancer Sci. 2006 Jun;97(6):468-77. doi: 10.1111/j.1349-7006.2006.00211.x.

The gene expression of hepatic proteins responsible for DNA repair and cell proliferation in tamoxifen-induced hepatocarcinogenesis.他莫昔芬诱导肝癌发生过程中负责DNA修复和细胞增殖的肝脏蛋白的基因表达

Cancer Sci. 2003 Jul;94(7):582-8. doi: 10.1111/j.1349-7006.2003.tb01486.x.

Gynecologic effects of tamoxifen: case reports and review of the literature.他莫昔芬的妇科效应：病例报告及文献综述

Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(4):179-84. doi: 10.1007/BF01907069.

Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Breast Cancer Res Treat. 1987;9(2):123-8. doi: 10.1007/BF01807364.

The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.类固醇激素受体分析在乳腺癌、子宫内膜癌和卵巢癌中的预测价值。

Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. doi: 10.1007/BF02934996.

Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.泼尼松龙可改善晚期乳腺癌对原发性内分泌治疗的反应。

Br J Cancer. 1988 Nov;58(5):626-30. doi: 10.1038/bjc.1988.273.

Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.环磷酰胺和他莫昔芬作为乳腺癌治疗的辅助疗法。CRC辅助性乳腺癌试验工作组。

Br J Cancer. 1988 Jun;57(6):604-7. doi: 10.1038/bjc.1988.137.

本文引用的文献

Adjuvant tamoxifen therapy for early breast cancer: an experimental study with reference to oestrogen and progesterone receptors.

Br J Surg. 1982 Mar;69(3):121-5. doi: 10.1002/bjs.1800690302.

The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.近期NSABP原发性乳腺癌治疗临床试验对肿瘤生物学理解的贡献——研究结果概述

Cancer. 1980 Aug 15;46(4 Suppl):1009-25. doi: 10.1002/1097-0142(19800815)46:4+<1009::aid-cncr2820461326>3.0.co;2-h.

Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level.

Recent Results Cancer Res. 1984;91:214-9. doi: 10.1007/978-3-642-82188-2_30.

Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.乳腺癌管理的未来前景：临床试验带来的生物学影响

Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.

Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.辅助性他莫昔芬治疗可手术乳腺癌：克里斯蒂医院和霍尔特镭研究所临床试验报告

Br Med J (Clin Res Ed). 1983 Mar 12;286(6368):827-30. doi: 10.1136/bmj.286.6368.827.

Chemotherapy of breast cancer: current views and results.

Int J Radiat Oncol Biol Phys. 1983 Mar;9(3):279-97. doi: 10.1016/0360-3016(83)90286-9.

Review of mortality results in randomised trials in early breast cancer.

Lancet. 1984 Nov 24;2(8413):1205.

Long-term survival of women with breast cancer.

Lancet. 1984 May 19;1(8386):1118. doi: 10.1016/s0140-6736(84)92525-x.

Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.早期乳腺癌乳房切除术后接受辅助性他莫昔芬治疗的患者生存率提高。

Lancet. 1983 Aug 20;2(8347):450. doi: 10.1016/s0140-6736(83)90406-3.

Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation.

Lancet. 1983 Feb 5;1(8319):257-61.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验